GammaDelta is focused on research into gamma delta T cells for potential use in immunotherapy, primarily addressing solid tumours More: Takeda snaps up GammaDelta Therapeutics Source: News
read moreIptacopan is an investigational, first-in-class, orally administered factor B inhibitor for the alternative pathway of the complement system More: Novartis UK awarded Innovation Passport for investigational therapy Source: News
read moreThe winners of the 2021 Clinical Researcher of the Year – The Americas have been announced, find out who emerged victorious More: Clinical Researcher of the Year – The Americas 2021 winners announced Source: News
read moreExperts say that it is vital to ensure that every member who is eligible for a vaccine has received one More: Double vaccinated can still spread COVID-19 at home, says UK study Source: News
read moreMerck’s big earnings in Q3 play second fiddle to enthusiasm for COVID pill’s potential kdunleavy Thu, 10/28/2021 – 11:15 More: Merck's big earnings in Q3 play second fiddle to enthusiasm for COVID pill's potential Source: fierce
read moreAlnylam founding CEO Maraganore steps down after pioneering RNA interference therapy aliu Thu, 10/28/2021 – 10:42 More: Alnylam founding CEO Maraganore steps down after pioneering RNA interference therapy Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals